Clinical Trial Update: Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.

View source ↗

Summary

This clinical trial update describes the development of prognostic models to predict response and toxicity to CAR-T cell therapy in patients with relapsed/refra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Non-Hodgkin Lymphoma | Status: NOT_YET_RECRUITING